Sign in

CIK 0001372299

  • Non-accelerated filer
  • Smaller reporting company

Ocugen, Inc.

Sign in to watch
Ticker
OCGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 484-328-4701
Business address
11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
Former names
HISTOGENICS CORP
  1. 4 Open-market buy Chief Financial Officer bought 5,000 shares at $0.28 ($1,400)
  2. 4 Open-market buy Director bought 100,000 shares at $0.41 ($41,000)
  3. 4 Open-market buy Director bought 4,000 shares at $1.48 ($5,920)
  4. 4 Open-market buy Chief Financial Officer bought 5,000 shares at $1.88 ($9,400)
  5. 4 Open-market buy Director bought 31,078 shares at an average $3.09 ($96,141)
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 4 Exercise or conversion 10% owner acquired 1,648,289 shares (option exercise)
  10. 4 Exercise or conversion Director acquired 1,648,289 shares (option exercise)
  11. 4 Exercise or conversion Director acquired 350,853 shares (option exercise)
  12. 4 Open-market sale 10% owner sold 998,204 shares at an average $0.16 ($158,772)
  13. 4 Open-market buy Director bought 230,768 shares
  14. 4 Open-market buy 10% owner bought 538,460 shares
  15. 4 Open-market buy Director bought 538,460 shares
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 10 of 15 · 288 filings